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Acetylcholine may contribute to the increase in regional cerebral blood flow (rCBF) during
cerebral activation since glycopyrrolate, a potent inhibitor of acetylcholine, abolishes the
exercise-induced increase in middle cerebral artery mean flow velocity. We tested the
hypothesis that cholinergic vasodilatation is important for the increase in rCBF during
cerebral activation. The subjects were 11 young healthy males at an age of 24 ± 3
years (mean ± SD). We used arterial spin labeling and blood oxygen level dependent
(BOLD) functional magnetic resonance imaging (fMRI) to evaluate rCBF with and
without intravenous glycopyrrolate during a handgrip motor task and visual stimulation.
Glycopyrrolate increased heart rate from 56 ± 9 to 114 ± 14 beats/min (mean ± SD;
p < 0.001), mean arterial pressure from 86 ± 8 to 92 ± 12mmHg, and cardiac output
from 5.6 ± 1.4 to 8.0 ± 1.7 l/min. Glycopyrrolate had, however, no effect on the arterial spin
labeling or BOLD responses to the handgrip motor task or to visual stimulation. This study
indicates that during a handgrip motor task and visual stimulation, the increase in rCBF
is unaffected by blockade of acetylcholine receptors by glycopyrrolate. Further studies on
the effect of glycopyrrolate on middle cerebral artery diameter are needed to evaluate the
influence of glycopyrrolate on mean flow velocity during intense exercise.
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INTRODUCTION
Cerebral blood flow (CBF) is 50–60ml 100 g−1 min−1 (Lassen,
1974) and its regional distribution is affected by cerebral neu-
ronal activity and metabolism (Lassen, 1959). Thus, a motor task
is followed by an increase in regional CBF (rCBF) (Olesen, 1971).
Although regulation of activity-related CBF is not fully under-
stood, it is considered to depend mainly on synaptic release of
glutamate that releases a series of vaso-active substances from
neurons and astrocytes (Attwell et al., 2010). However, other
substances such as acetylcholine may be involved in maintain-
ing CBF during, e.g., a change in perfusion pressure (Hamner
et al., 2012). The endothelium is important for cerebral vasoreg-
ulation and acetylcholine interacts with endothelial muscarinic
receptors (Tsukahara et al., 1986) to facilitate vasodilation (Faraci
and Heistad, 1991). Intrinsic and extrinsic regulation of cere-
bral vessels and in turn CBF is described by Hamel (2006), and
cerebral blood vessels receive cholinergic innervation originat-
ing mainly from the sphenopalatine ganglion and the nucleus
basalis of Meynert (NBM) (Seylaz et al., 1988; Suzuki et al., 1990).
The increase in rCBF during walking appears to include exci-
tation of this NBM-originating cholinergic vasodilation system
(Sato and Sato, 1995), suggesting a link between acetylcholine
mediated control of vessels, and activity-dependent changes in
perfusion. Similarly, the transcranial Doppler (TCD) ultrasound
determined mean blood velocity for the contralateral middle
cerebral artery (MCA Vmean) increases during handgrip exercise
(Jørgensen et al., 1993) and Vmean increases for the contralateral
anterior cerebral artery (ACA) during movement of one foot
while cycling exercise is associated with a bilateral increase in both
MCA and ACA Vmean (Linkis et al., 1995). Activity of the cholin-
ergic fibers induces increase in rCBF in dogs (D’Alecy and Rose,
1977; Toda et al., 2000) although there are conflicting findings
as to the effect of atropine in blocking this dilation (D’Alecy and
Rose, 1977; Busija and Heistad, 1981; Toda et al., 2000). However,
there may be important differences among species. In swine the
absence of change in perfusion to cortical areas of cerebrum
during running (Delp et al., 2001) suggests that in quadrupeds
running does not require higher brain activation. Accordingly,
Hamner et al. (2012) suggest that cholinergic involvement in
human CBF regulation needs to be directly addressed.
Acetylcholinesterase inhibitors that pass the blood brain bar-
rier are used to reduce symptoms of Alzheimer’s disease and
vascular cognitive impairment (Birks and Harvey, 2006; Levine
and Langa, 2011) possibly indicating a cholinergic contribution
to regulation of CBF and cerebral metabolism. For other drugs
crossing the blood brain barrier, such as atropine, the effect
on CBF may be secondary to changes in cerebral metabolism.
Glycopyrrolate is a similar muscarinic blocker that does not cross
the blood brain barrier (Proakis and Harris, 1978) and dur-
ing handgrip and cycling exercise, glycopyrrolate abolishes the
exercise-induced increase in MCA Vmean (Seifert et al., 2010).
This leads to the hypothesis that cholinergic vasodilatation is
important for the motor task-induced increase in cerebral perfu-
sion, not only during strenuous exercise, but also at a moderate
www.frontiersin.org February 2014 | Volume 5 | Article 45 | 1
Rokamp et al. Glycopyrrolate and regional CBF
activity level. We hypothesized that cholinergic vasodilation
would induce an increase in rCBF upon cerebral activation. In
order to test that hypothesis, we used arterial spin labeling (ASL)
and blood oxygen level dependent (BOLD) functional magnetic
resonance imaging (fMRI) to assess CBF with and without gly-
copyrrolate at rest and during a handgrip motor task and also
during visual light stimulation.
METHODS
The subjects were 11 young healthy males at an age of 24 ± 3
years (height and weight 183 ± 6 cm, and 78 ± 9 kg; mean ±
SD). The study was approved by the local ethical committee (J.nr.
H-4-2010-066) and by the Danish Data Protection Agency (J.nr.
2011-41-6602) and written informed consent was obtained prior
to participation in accordance with the Declaration of Helsinki.
Inclusion criteria were male gender, being healthy non-smoker
without taking any medication. The subjects abstained from
strenuous physical activity on the day prior to the study and from
caffeine on study days.
A catheter was inserted in an arm vein for administration
of glycopyrrolate and also a catheter was placed in the radial
artery of the non-dominant arm for blood sampling and cardio-
vascular measurements. Heart rate (HR) was monitored using
a lead II ECG and arterial pressure was measured with a trans-
ducer (Edwards Life Sciences, Irvine, CA) at heart level and
connected to a monitor (Dialogue-2000 IBC-Danica Electronic,
Copenhagen, Denmark). Heart rate variability was quantified
from data acquired at rest as the standard deviation of RR-
interval duration divided by the mean duration. Mean arterial
pressure (MAP), cardiac stroke volume (SV) and output (CO)
were determined from the radial arterial pressure using pulse
contour methodology (Nexfin, BMEYE B.V, Amsterdam, The
Netherlands) (Bogert and Van Lieshout, 2005).
Magnetic resonance imaging was performed on a 3.0T Intera
Achieva scanner (PhilipsMedical Systems, Best, The Netherlands)
using an eight-element phased array receiver head coil. Structural
imaging was performed using a 3D T1 weighted gradient echo
sequence [repetition time (TR) = 10ms, echo time (TE) = 5ms,
flip angle 8◦, matrix 240 × 200, voxel size 1 × 1× 1mm, sensitiv-
ity encoding (SENSE) factor = 2]. The structural scan was used
for tissue segmentation and calculation of brain volume.
Global brain perfusion was determined with velocity mapping
using phase subtraction of a flow compensated and flow sensi-
tive gradient echo sequence. Measurements were obtained with
a matrix of 320 × 320 (TR = 12ms, TE = 7ms, flip angle 10◦,
voxel size 0.75 × 0.75 × 8mm). The sequence was ECG gated
(retrospective gating, 20 frames/cycle), using a velocity encod-
ing of 150 cm/s. Any aliasing of the phase-difference was cor-
rected using an in-house written routine for Matlab v 7.9 (The
MathWorks Inc., Natick, MA). A fast angiography was performed
and reconstructed in order for the imaging section to be posi-
tioned perpendicular to the cavernous segment of the internal
carotid and basilar arteries.
Regional perfusion maps were obtained with ASL using the
QUASAR sequence (Petersen et al., 2006). The sequence is based
on multi-slice pulsed arterial labeling technique (EPISTAR) in
which both the labeling and the control experiment are preceded
by a saturation pulse and followed by a QUIPSS-II type satura-
tion pulse. The readout was performed using a dual flip angle
Look-Locker strategy and both crushed and non-crushed control-
label pairs were acquired. General scan parameters were: TR =
4000ms; TE = 22ms, multiple time-point interval (TI) =
300ms, time of first readout (TI1) = 40ms, flip angle 35/11.7◦,
matrix 80 × 80, voxel size 3 × 3× 6mm, gap 1.5mm, SENSE fac-
tor= 2.5, 84 averages [48 at velocity encoding (Venc) = 4 cm/s, 24
without velocity encoding, 12 at low flip angle]. Seven transaxial
perfusion slices parallel to the lower edges of the corpus callosum
were acquired with a total scan duration of 6min.
Functional imaging was carried out at rest and during task
conditions using a standard gradient-echo EPI sequence with 32
slices positioned parallel to and overlapping the ASL acquisition.
Variables were: TR = 3000ms, TE = 35ms, flip angle 90◦, FOV
230 × 230mm2, in plane resolution 2.9 × 2.9mm2, slice thick-
ness 4.0mm, and inter slice gap 0.1mm. For each run during
task paradigms, 70 frames were obtained and for the resting state
experiments, 300 frames were obtained.
The subjects were placed supine and run through a sequence
of 2 times 30min of scanning, the first being without influ-
ence of glycopyrrolate (Table 1).Measurements of global (velocity
mapping) and regional (ASL) brain perfusion were performed
with the subject at rest and while squeezing a rubber ball
which required 36 N for 50% compression (Thera-Band® Hand
Exerciser, prod. no. 26050, The Hygenic Corporation, 1245 Home
Ave., Akron, OH 44310, USA). We instructed the subjects to com-
press the rubber ball by rhythmic squeezing ∼30–60 times per
minute with as much effort as possible, while lying still with the
rest of the body.
Two runs of BOLD imaging were performed with different
tasks, one in which the subject was stimulated visually with a
checkerboard pattern reversing at 8Hz. Furthermore, the subject
was instructed to carry out sequential finger-thumb opposition
on both hands while the checkerboard was on. In the other run,
the subject squeezed the rubber ball intermittently with no visual
stimulation. Both runs included 5 resting periods interleaved with
4 active, each lasting 30 s. Additionally, for assessment of intrinsic
connectivity, BOLD data were acquired with the same variables,
but for 900 s without any tasks imposed.
Arterial samples were obtained at rest in 8 subjects. The
samples were emptied of any atmospheric content and imme-
diately analyzed for carbon dioxide tension (PaCO2) (ABL 725,
Radiometer, Copenhagen, Denmark), before and after the scan-
ning sequence with and without glycopyrrolate. To induce cholin-
ergic receptor blockade the subjects received 1.9 ± 0.34mg of
glycopyrrolate by stepwise infusions of 0.2mg until no further
increase in HR could be established.
REGION BASED fMRI ANALYSIS
Motor cortex (BA1) on the contralateral side of the activated
dominant hand was drawn in the center of the anatomically
defined region, around the area of maximal activation. Similarly,
in the activated area in visual cortex (BA17) a central and
extended area was delineated. The extended BA17 area corre-
sponds to the entire region (left side) as defined the MNI/Juelich
atlas. Data are derived from 22 measurements in 11 subjects.
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Table 1 | The study protocol.
Time (min) Baseline vs. glycopyrrolate Scanning sequence Arterial blood gas measurement



















BOLD-fMRI—visual and motor task
BOLD-fMRI—motor task
110min 4. PaCO2
With the subjects placed in the scanner, two sets of measurements were obtained, the first (baseline) being without influence of glycopyrrolate. Global flow was
obtained by velocity mapping in the carotid and basilar arteries, using phase subtraction. In addition, measurements included arterial spin labeling (ASL) and blood
oxygen level dependent (BOLD) functional magnetic resonance imaging (fMRI).
STATISTICAL ANALYSIS
Variables were analyzed in STATA/SE v 11.2 (www.stata.com)
using a random effect linear model and a p-value < 0.05
was considered statistically significant. Results are presented as
mean ± SD. Functional BOLD data were analyzed using FSL v.
4.1.2 (FMRIB Software Library, www.fmrib.ox.ac.uk/fsl). Data
were spatially aligned to correct for subject motion and slice
timing differences and filtered with a temporal highpass filter
matched to the paradigm period (60 s). Spatial filtering was with
a 5mm gaussian filter. Thresholding for positive and negative
effects was done using a cluster based approach with a primary
threshold of z > 2.3 and a cluster-level p-value of 0.05. The
response magnitude was calculated and reported as average over




The cardiovascular effects of glycopyrrolate and the handgrip
motor task are presented in Table 2. Glycopyrrolate increased HR
from 56 ± 9 to 114 ± 14 beats/min (p < 0.001), diastolic (DIA)
and MAP from 69 ± 7 to 82 ± 10mmHg and from 86 ± 8 to
92 ± 12mmHg, respectively, and CO from 5.6 ± 1.4 to 8.0 ±
1.7 l/min, while HR variability decreased from 5.0 ± 1.6 to 1.5 ±
0.4% (P < 0.001). In contrast, no effect was observed for systolic
Table 2 | Cardiovascular variables.
Cardiovascular Resting Resting + Motor task Motor task +
glycopyrrolate glycopyrrolate
SYS (mmHg) 119±15 119±12ns 124±19ns 123± 15ns
DIA (mmHg) 69±7 82±10* 72±8ns 84± 8**
MAP (mmHg) 86±8 92±12ns 89±10ns 93± 10ns
HR (B min−1) 56±9 114±14** 61±7ns 115± 13**
SV (ml) 101±20 71±16* 101±22ns 72± 14*
CO (l min−1) 5.6±1.4 8.0±1.7* 6.2±1.6ns 8.1± 1.3*
CBF (ml/min) 797±162 817±203ns 856±162ns 837± 204ns
SYS, DIA, MAP systolic, diastolic, and mean arterial pressure, respectively; HR,
heart rate; SV, cardiac stroke volume; CO, cardiac output; CBF, cerebral blood
flow. Values are mean ± SD. Testing performed with paired t-test vs. Resting
(without glycopyrrolate). ns, non-significant; *p < 0.05 and **p < 0.001.
pressure (SYS). The handgrip motor task increased DIA andMAP
by 4 and 5mmHg, respectively (P < 0.001), but no significant
changes were observed for SYS, HR, or CO. There was no inter-
action between glycopyrrolate and the handgrip motor task or
visual stimulation on any of the cardiovascular variables. Also
there was no significant difference between data obtained during
the different MR measurements or the arterial blood gas samples
(Table 3).
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Table 3 | Arterial pH and carbon dioxide tension (PaCO2).
Rest Resting + Motor task Motor task +
glycopyrrolate glycopyrrolate
pH 7.40±0.01 7.40± 0.02 7.40± 0.02 7.41±0.02
PaCO2 (kPa) 5.4±0.2 5.5± 0.5 5.5± 0.3 5.2±0.4
Values are mean ± SD.
WHOLE BRAIN FLOW VELOCITY MAPPING BY PHASE ENCODING
The total arterial flow to the brain was 801ml/min, with an inter-
subject SD of 156ml/min (19.5%) and an intra-subject SD of
64ml/min (8%) (Table 2). There was no significant effect of acti-
vation of handgrip or glycopyrrolate for the total or any of the
three vessels [right and left internal carotid artery (ICA) or basi-
lar artery]. The average maximal velocity for, e.g., the left ICA was
76 cm/s, with almost equal inter and intra-subject SD of 33 and
32 cm/s. For the right and the left ICA there was no significant
effect of glycopyrrolate.
CEREBRAL PERFUSION (ARTERIAL SPIN LABELING)
Six subjects were evaluated with handgrip activation. Handgrip
increased total gray matter CBF from 46 to 51ml 100 mg−1
min−1 (P = 0.01), but the increase was not significantly altered
by glycopyrrolate. Similarly, arterial spin labeling maps showed
an area of significant flow increase corresponding to the left pri-
mary motor cortex during handgrip (p < 0.001, uncorrected),
with no significant modulation during glycopyrrolate. However,
a decrease in perfusion was seen in areas corresponding to the
posterior cingulate and parietal cortices during glycopyrrolate
(p < 0.001, uncorrected).
BLOOD OXYGEN LEVEL DEPENDENT ACTIVATION DURING HANDGRIP
There was an increase of the BOLD signal during activation of
the motor cortex (BA1) on the contra-lateral side of the activated
dominant hand by 2.16% compared with the resting value (P <
0.001), but there was no effect of glycopyrrolate at voxel level.
BLOOD OXYGEN LEVEL DEPENDENT ACTIVATION DURING COMBINED
VISUAL STIMULATION AND MOTOR TASK
The main effect of visuo-motor stimulation was a massive acti-
vation in extended areas centered around motor cortex (bilateral
BA1), and visual cortex (BA17) and also including basal ganglia
and cerebellum (Figure 1). In area BA1 on the contralateral side
of the activated dominant hand, the BOLD response increased
1.9% during finger tapping and visual stimulation when com-
pared to rest. In area (BA17) of the visual cortex the BOLD
response increased by 2.76% in the central area and 1.16% in the
extended area in response to visual stimulation and finger tapping
when compared to rest (P < 0.001). No effect of glycopyrrolate
was observed.
DISCUSSION
As expected, motor activation increased rCBF in motor cortex
as indicated by BOLD and arterial spin labeling. The increase
in rCBF did not affect total CBF as measured by phase map-
ping and apparently only whole body exercise increases total CBF.
The dynamic behavior of CBF is supported by the increase in
CBF during whole body exercise as detected by 133Xe clearance
(Thomas et al., 1989) and by TCD (Jørgensen et al., 1992a,b),
but in the present study we did not find any increase in CBF in
spite of an increase in CO from 5.7 to 7.9 l/min during infusion of
glycopyrrolate, nor an effect on rCBF during motor- and visual
activation. Furthermore, we were not able to demonstrate that
glycopyrrolate affected CBF increase during visual stimulation or
a handgrip motor task.
Seifert et al. (2010) report that glycopyrrolate attenuated the
increase in CBF during sustained handgrip and cycle exercise.
There are several differences between the two studies, the most
apparent being different modes of motor- and neural activa-
tion of the subjects and different methods of measuring brain
blood velocity and flow. In our study handgrip increased MAP
by about 5mmHg, while no significant differences were induced
in HR or CO, whereas, in comparison sustained handgrip in the
study of Seifert et al. increased MAP, HR, and CO, 30mmHg, 45
beats min−1 and 3.5 L min−1, respectively. Cerebral blood ves-
sels are surrounded by nerve fibers that originate, respectively,
from extrinsic peripheral nerve ganglia (sphenopalatine, otic, or
trigeminal ganglion) and intrinsic brain neurons and contributes
to the functional “neurovascular unit” where the vascular tone
is regulated by both intrinsic and extrinsic innervation (Hamel,
2006). In our study the test persons may not be considered to
perform “exercise,” but rather a light motor task and therefore,
one can speculate that the intrinsic regulation is dominating
an intravascular cholinergic stimulus. The study of Seifert et al.
(2010) measured differences after strenuous exercise, including
muscular pain, increased HR, CO, and respiratory frequency,
where an extrinsic component might be of more importance.
Since glycopyrrolate does not cross the blood brain barrier and
therefore cannot affect the intrinsic regulation, a possible effect
of blocking the cholinergic response might have been unob-
served, or the cholinergic vasodilatation is only important under
conditions where acetylcholine release from neuromuscular junc-
tions influences total cerebrovascular reactivity, but not for the
exercise-induced increase in regional cerebral perfusion during a
handgrip motor task or visual stimulation.
The methods for measuring blood velocity and flow were dif-
ferent in the two studies. Seifert et al. (2010) used TCDof themid-
dle cerebral artery. When measuring cerebral blood velocity using
Q-flow, we considered that the small diameter ofMCAwould lead
to an underestimate of flow because of a partial volume effect. We
therefore, used the ICA although this measurement is directed
toward total CBF compared to MCA where the motor cortex
would represent a larger percentage of the distribution area. For
measuring local cerebral blood perfusion we used ASL and BOLD.
Being an indirect method of measuring cerebral perfusion, the
BOLD technique measures changes in deoxyhemoglobin con-
centration that correlates to changes in local perfusion in the
absence of metabolic changes, the cerebral tissue being unin-
fluenced by glycopyrrolate that does not cross the blood brain
barrier. Importantly the CBF/perfusion baseline was not altered
after administration of glycopyrrolate in neither study.
This study could be underpowered considering the increase in
CBF during motor activity is about 60ml/min during placebo
and 20ml/min during glycopyrrolate, but with the standard
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FIGURE 1 | Main effect of visuo-motor stimulation, large
activation in extended areas centered around motor cortex
(bilateral BA1), and visual cortex (BA17), but also including
basal ganglia and cerebellum. When properly corrected for
multiple comparison or corrected voxel level (p < 0.05) there is no
effect of glycopyrrolate.
deviations above 150ml/min, a very large sample would be
needed in order to detect a potential effect of hand activity on
global perfusion.
Although not a primary endpoint, we observed scattered areas
of decreased perfusion during glycopyrrolate, especially in the
posterior cingulate area. This finding is of potential interest,
since posterior and parietal areas are affected early in the course
of Alzheimer’s disease in which cholinergic innervation may be
deficient. A regionally specific effect of glycopyrrolate on brain
perfusion has not been described and would need investigation in
future studies.
LIMITATIONS
The study is limited by the use of glycopyrrolate that does not
cross the blood brain barrier and therefore, does not have any
metabolic effect on cerebral tissue. Glycopyrrolate is therefore
limited to influence the extrinsic innervation of the functional
“neurovascular unit” leaving the intrinsic innervation unaffected.
When performing a handgrip motor task or visual stimulation,
the intrinsic innervation might be dominating and therefore
mask the effect of cholinergic blockade.
Compressing an ergo ball rhythmically with the same force is
not easily standardized and therefore, different levels of cerebral
activation could bias the results, but there is no difference between
handgrip task and light stimulation in interindividual cerebral
blood perfusion response which supports the validity of the
handgrip data.
The measurement of BOLD is an indirect measurement of
cerebral perfusion as it determines changes in deoxyhemoglobin
concentration that correlates to those in local perfusion in the
absence of metabolic changes. The cerebral tissue being unin-
fluenced by glycopyrrolate, that do not cross the blood brain
barrier, should therefore be without metabolic influence leav-
ing the effect of cholinergic blockade to the extrinsic part of the
neurovascular unit.
CONCLUSION
Cerebral blood flow is not altered by glycopyrrolate during a
motor task or visual stimulation as measured by fMRI. Further
studies on the effect of glycopyrrolate on CBF comparing stren-
uous and light exercise using fMRI is needed to contribute to
understanding the role of extrinsic vs. intrinsic cholinergic inner-
vation on the regulation of CBF.
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